tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
Want to see GB:STX full AI Analyst Report?

Shield Therapeutics (STX) Technical Analysis

42 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 4.66, while Shield Therapeutics PLC’s (STX) share price is 6.15 p, making it a Buy.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 5.36, while Shield Therapeutics PLC’s (STX) share price is 6.15 p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Aug 25, 2026, 07:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.52
3.91
4.41
4.80
5.30
5.69
6.19
Fibonacci
3.91
4.25
4.46
4.80
5.14
5.35
5.69
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Aug 25, 2026, 07:44 AM
Period
Simple
Exponential
MA5
4.59Buy
4.64Buy
MA10
4.38Buy
4.52Buy
MA20
4.43Buy
4.66Buy
MA50
5.53Sell
5.36Sell
MA100
6.52Sell
6.23Sell
MA200
8.05Sell
7.31Sell
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 4.52, while Shield Therapeutics PLC’s (STX) share price is 6.15 p, making it a Buy.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 6.23, while Shield Therapeutics PLC’s (STX) share price is 6.15 p, making it a Sell.
Shield Therapeutics PLC’s (STX) stock price is 6.15 p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 5.53, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 6.15 p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 6.52, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 6.15 p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 8.05, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

Aug 25, 2026, 07:44 AM
Name
Value
Implied Action
RSI (14)
50.50
Neutral
STOCH (9,6)
74.33
Neutral
STOCHRSI (14)
75.56
Neutral
MACD (12,26)
-0.28
Sell
ADX (14)
35.68
Neutral
Williams %R
-23.33
Buy
CCI (14)
49.02
Neutral
ATR (14)
0.40
-
Ultimate Oscillator
52.84
Neutral
ROC
22.78
Buy
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 50.50, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 35.68, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is 49.02, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is 22.78, creating a Buy signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Hold.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 50.50, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is -0.28, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 4.59, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 4.43, which suggests STX is a Buy.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 5.53, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 8.05, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -23.33, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is 49.02, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics PLC?